Ligand Pharmaceuticals
LGND
#3475
Rank
NZ$6.96 B
Marketcap
NZ$349.30
Share price
-0.02%
Change (1 day)
85.90%
Change (1 year)

P/S ratio for Ligand Pharmaceuticals (LGND)

P/S ratio as of April 2026 (TTM): 14.8

According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.91. At the end of 2025 the company had a P/S ratio of 14.0.

P/S ratio history for Ligand Pharmaceuticals from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
202514.013.06%
202412.330.17%
20239.4845.3%
20226.53-29.93%
20219.318.57%
20208.58-41.18%
201914.630.16%
201811.2-45.29%
201720.55.1%
201619.5-35.21%
201530.186.35%
201416.1-26.59%
201322.056.36%
201214.180.84%
20117.775.16%
20107.3913.73%
20096.50-31.74%
20089.52-73.03%
200735.3142.56%
200614.6192.86%
20054.97-7.18%
20045.36-29.68%
20037.6291.88%
20023.97-71.82%
200114.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.22-58.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.57-82.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
12.8-13.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
5.10-65.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
0.7658-94.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.60-69.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.52-82.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.61-82.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
8.22-44.66%๐Ÿ‡บ๐Ÿ‡ธ USA